In furtherance of its commitment towards providing excellent and world-class oncological diagnostics, Me Cure Healthcare has unveiled the first ever cyclotron and PET-CT scan in West Africa. The event, which took place at the company’s Oncology Centre in Lagos, on Monday, 12 December, 2022, had in attendance captains of industry, banking executives and distinguished stakeholders in the health sector, including pharmacists, doctors and lab scientists.
The unveiling was officially done by the Acting Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Pharm. (Dr) Monica Eimunjeze, who eulogised the management of Me cure Healthcare for working assiduously over the years to provide innovative diagnostic solutions that had been difficult to access before now.
A release made available to Pharmanewsonline by Me Cure’s media department reads: “Cyclotron is a device that produces PET-CT tracers and other radiopharmaceutical reagents that are used to detect the physiological activities of cancer cells in the body which is different from the conventional CT scan that detect only anatomical structure with less accuracy.
“This uncommon medical device is located in the beautiful six-floor Me Cure Cancer Centre located in Nigeria and it is expected to be the first most comprehensive world class cancer centre in West Africa.
“The arrival of the cyclotron will reverse medical tourism and reduce the stress and cost of cancer care in Nigeria. Hence, it is good news for the entire Oncology patients, Nigeria and West Africa. The power behind all this set-up is Sir Samir Udani, who is the chairman of Me Cure Industries.
“The services are expected to be provided by Certified and experienced professionals and managed by Dr Adeoluwa Adeniji, who is the chief medical director and consultant radiation/clinical oncologist and Mr Daniel Kassegbama, who is the chief operating officer with many years of experience in management processes.”
Beyond making history, the unveiling of the first ever cyclotron and PET-CT scan in West Africa attests to Me Cure’s philosophy of excellence and problem solving in the diagnostic industry where competition is rife. It also underscores the company’s leadership in the oncological services niche in Nigeria and the whole of West Africa.
